Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience.
about
Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects.Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study.Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potential therapeutic regime for bladder cancer immunotherapy.Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity.
P2860
Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Improved patient outcomes with ...... dish and worldwide experience.
@ast
Improved patient outcomes with ...... dish and worldwide experience.
@en
type
label
Improved patient outcomes with ...... dish and worldwide experience.
@ast
Improved patient outcomes with ...... dish and worldwide experience.
@en
prefLabel
Improved patient outcomes with ...... dish and worldwide experience.
@ast
Improved patient outcomes with ...... dish and worldwide experience.
@en
P356
P1433
P1476
Improved patient outcomes with ...... dish and worldwide experience.
@en
P2093
Malmström P
P356
10.1159/000052377
P407
P478
37 Suppl 1
P577
2000-01-01T00:00:00Z